OTC Drug Stability Program & Shelf Life Determination Requirements
Introducing FDA requirements for finished OTC stability programs, testing parameters, active assay decay, and shelf-life calculations.
All OTC drug products must be supported by stability testing data to justify their expiration dates. Per 21 CFR 211.166, stability studies must use the commercial container closure system, stored under defined settings (typically 25°C ± 2°C / 60% ± 5% RH for long-term). Key parameters cover active assay, degradants, microbial counts, and physical attributes.
Key Parameters of an OTC Stability Protocol
The stability protocol is a primary document checked during GMP audits. A compliant testing design must include the following details.
- Sampling points: 0, 3, 6, 9, 12 months for year 1, and at least annually thereafter
- Commercial container: samples must be in the exact plastic bottles/tubes sold, not generic jars
- Ongoing stability: once marketed, at least one batch per strength must enter the ongoing program annually
FAQ
Can accelerated data justify a 2-year expiration date?+
Yes, tentatively. The FDA allows temporary shelf life (typically up to 2 years) based on 6-month accelerated data (40°C/75% RH) at initial launch. However, the manufacturer must run concurrent long-term tests to verify the period and archive the logs.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
